Merrett Gemma L Buckland, Bloom Gerald, Wilkinson Annie, MacGregor Hayley
Health Action International, Overtoom 60 (2), 1054 HK Amsterdam, The Netherlands.
Institute of Development Studies, Library Road, Brighton, BN1 9RE UK.
J Pharm Policy Pract. 2016 Oct 7;9:31. doi: 10.1186/s40545-016-0083-5. eCollection 2016.
The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-makers, who need to oversee the transformation of health systems that evolved to provide easy access to these drugs into ones that encourage appropriate use of antimicrobials, whilst reducing the risk of resistance. This is a particular challenge for low and middle-income countries with pluralistic health systems where antibiotics are available in a number of different markets. This review paper considers access and use of antibiotics in these countries from a complex adaptive system perspective. It highlights the main areas of intervention that could provide the key to addressing the sustainable long term use and availability of antibiotics. A focus on the synergies between interventions addressing access strategies, antibiotic quality, diagnostics for low-resource settings, measures to encourage just and sustainable decision making and help seeking optimal therapeutic and dosing strategies are key levers for the sustainable future of antibiotic use. Successful integration of such strategies will be dependent on effective governance mechanisms, effective partnerships and coalition building and accurate evaluation systems at national, regional and global levels.
抗生素耐药性病原体的出现和传播给政策制定者带来了巨大挑战,他们需要监督卫生系统的转型,即从一个旨在方便获取这些药物的系统转变为鼓励合理使用抗菌药物、同时降低耐药风险的系统。对于有着多元卫生系统且抗生素在多个不同市场均可获取的低收入和中等收入国家而言,这是一项特殊挑战。本综述文章从复杂适应系统的角度探讨了这些国家抗生素的获取与使用情况。它突出了主要干预领域,这些领域可能是解决抗生素可持续长期使用和供应问题的关键。关注解决获取策略、抗生素质量、低资源环境下的诊断、鼓励公正和可持续决策的措施以及寻求最佳治疗和给药策略之间的协同作用,是抗生素可持续未来使用的关键杠杆。这些策略的成功整合将依赖于国家、区域和全球层面有效的治理机制、有效的伙伴关系与联盟建设以及准确的评估系统。